British national formulary 68, September 2014 - March 2015.

Include index.

pharmacy bookfair2015

"published under the authority of a Joint Formulary Committee"-pref.

Cover -- Preface -- Contents -- General Information -- Acknowledgements -- BNF Staff -- Joint Formulary Committee 2011-2012 -- Dental Advisory Group 2011-2012 -- Nurses Prescribers' Advisory Group 2011-2012 -- How the BNF is constructed -- How to use the BNF -- Changes for this edition -- Guidance on prescribing -- General guidance -- Prescription writing -- Emergency supply of medicines -- Controlled Drugs and drug dependence -- Adverse reactions to drugs -- Prescribing for children -- Prescribing in hepatic impairment -- Prescribing in renal impairment -- Prescribing in pregnancy -- Prescribing in breast-feeding -- Prescribing in palliative care -- Prescribing for the elderly -- Prescribing in dental practice -- Drugs and sport -- Emergency treatment of poisoning -- 1 Gastro-intestinal system -- 1.1 Dyspepsia and gastro-oesophageal reflux disease -- 1.2 Antispasmodics and other drugs altering gut motility -- 1.3 Antisecretory drugs and mucosal protectants -- 1.4 Acute diarrhoea -- 1.5 Chronic bowel disorders -- 1.6 Laxatives -- 1.7 Local preparations for anal and rectal disorders -- 1.8 Stoma care -- 1.9 Drugs affecting intestinal secretions -- 2 Cardiovascular system -- 2.1 Positive inotropic drugs -- 2.2 Diuretics -- 2.3 Anti-arrhythmic drugs -- 2.4 Beta-adrenoceptor blocking drugs -- 2.5 Hypertension and heart failure -- 2.6 Nitrates, calcium-channel blockers, and other antianginal drugs -- 2.7 Sympathomimetics -- 2.8 Anticoagulants and protamine -- 2.9 Antiplatelet drugs -- 2.10 Stable angina, acute coronary syndromes, and fibrinolysis -- 2.11 Antifibrinolytic drugs and haemostatics -- 2.12 Lipid-regulating drugs -- 2.13 Local sclerosants -- 3 Respiratory system -- 3.1 Bronchodilators -- 3.2 Corticosteroids -- 3.3 Cromoglicate and related therapy, leukotriene receptor antagonists, and phosphodiesterase type-4 inhibitors.
3.4 Antihistamines, hyposensitisation, and allergic emergencies -- 3.5 Respiratory stimulants and pulmonar surfactants -- 3.6 Oxygen -- 3.7 Mucolytics -- 3.8 Aromatic inhalations -- 3.9 Cough preparations -- 3.10 Systemic nasal decongestants -- 4 Central nervous system -- 4.1 Hypnotics and anxiolytics -- 4.2 Drugs used in psychoses and related disorders -- 4.3 Antidepressant drugs -- 4.4 CNS stimulants and drugs used for attention deficit hyperactivity disorder -- 4.5 Drugs used in the treatment of obesity -- 4.6 Drugs used in nausea and vertigo -- 4.7 Analgesics -- 4.8 Antiepileptic drugs -- 4.9 Drugs used in parkinsonism and related disorders -- 4.10 Drugs used in substance dependence -- 4.11 Drugs for dementia -- 5 Infections -- 5.1 Antibacterial drugs -- 5.2 Antifungal drugs -- 5.3 Antiviral drugs -- 5.4 Antiprotozoal drugs -- 5.5 Anthelmintics -- 6 Endocrine system -- 6.1 Drugs used in diabetes -- 6.2 Thyroid and antithyroid drugs -- 6.3 Corticosteroids -- 6.4 Sex hormones -- 6.5 Hypothalamic and pituitary hormones and anti-oestrogens -- 6.6 Drugs affecting bone metabolism -- 6.7 Other endocrine drugs -- 7 Obstetrics, gynaecology, and urinary-tract disorders -- 7.1 Drugs used in obstetrics -- 7.2 Treatment of vaginal and vulval conditions -- 7.3 Contraceptives -- 7.4 Drugs for genito-urinary disorders -- 8 Malignant disease and immunosuppression -- 8.1 Cytotoxic drugs -- 8.2 Drugs affecting the immune response -- 8.3 Sex hormones and hormone antagonists in malignant disease -- 9 Nutrition and blood -- 9.1 Anaemias and some other blood disorders -- 9.2 Fluids and electrolytes -- 9.3 Intravenous nutrition -- 9.4 Oral nutrition -- 9.5 Minerals -- 9.6 Vitamins -- 9.7 Bitters and tonics -- 9.8 Metabolic disorders -- 10 Musculoskeletal and joint diseases -- 10.1 Drugs used in rheumatic diseases and gout -- 10.2 Drugs used in neuromuscular disorders.
10.3 Drugs for the treatment of soft-tissue disorders and topical pain relief -- 11 Eye -- 11.1 Administration of drugs to the eye -- 11.2 Control of microbial contamination -- 11.3 Anti-infective eye preparations -- 11.4 Corticosteroids and other anti-inflammatory preparations -- 11.5 Mydriatics and cycloplegics -- 11.6 Treatment of glaucoma -- 11.7 Local anaesthetics -- 11.8 Miscellaneous ophthalmic preparations -- 11.9 Contact lenses -- 12 Ear, nose, and oropharynx -- 12.1 Drugs acting on the ear -- 12.2 Drugs acting on the nose -- 12.3 Drugs acting on the oropharynx -- 13 Skin -- 13.1 Management of skin conditions -- 13.2 Emollient and barrier preparations -- 13.3 Topical localan aesthetics and antipruritics -- 13.4 Topical corticosteroids -- 13.5 Preparations for eczema and psoriasis -- 13.6 Acne and rosacea -- 13.7 Preparations for warts and calluses -- 13.8 Sunscreens and camouflagers -- 13.9 Shampoos and other preparations for scalp and hair conditions -- 13.10 Anti-infective skin preparations -- 13.11 Skin cleansers, antiseptics, and desloughing agents -- 13.12 Antiperspirants -- 13.13 Topical circulatory preparations -- 14 Immunological products and vaccines -- 14.1 Active immunity -- 14.2 Passive immunity -- 14.3 Storage and use -- 14.4 Vaccines and antisera -- 14.5 Immunoglobulins -- 14.6 International travel -- 15 Anaesthesia -- 15.1 General anaesthesia -- 15.2 Local anaesthesia -- Appendix 1 Interactions -- Appendix 2 Borderline substances -- A2.1 Enteral feeds (non-disease specific) -- A2.2 Nutritional supplements (non-disease specific) -- A2.3 Specialised formulas -- A2.4 Feed supplements -- A2.5 Feed additives -- A2.6 Foods for special diets -- A2.7 Nutritional supplements for metabolic diseases -- Appendix 3 Cautionary and advisory labels for dispensed medicines -- Appendix 4 Intravenous additives.
Appendix 5 Wound management products and elasticated garments -- A5.1 Basic wound contact dressings -- A5.2 Advanced wound dressings -- A5.3 Antimicrobial dressings -- A5.4 Specialised dressings -- A5.5 Adjunct dressings and appliances -- A5.6 Complex adjunct therapies -- A5.7 Wound care accessories -- A5.8 Bandages -- A5.9 Compression hosiery and garments -- Dental Practitioners' Formulary -- Nurse Prescribers' Formulary -- Non-medical prescribing -- Index of manufacturers -- Special-order Manufacturers -- Index -- Yellow Card -- Cardiovascular Risk Prediction Charts -- Adult Advanced Life Support Algorithm -- Medical emergencies in thecommunity -- General reference -- Approximate conversions and units -- Prescribing for children -- Recommended wording of cautionary and advisory labels -- Abbreviations and symbols -- Latin abbreviations -- E numbers.

Nobody working in healthcare can afford to be without the latest
edition of the British National Formulary. Compiled with the
advice of clinical experts and continually updated to reflect the
latest evidence from all credible sources worldwide, this essential
reference provides up-to-date guidance on prescribing,
dispensing, administering, and monitoring medicines. Not only
does the BNF include the widely accepted framework for the drug
management of common diseases, it also includes details of
medicines prescribed in the UK, with special reference to their
uses, cautions, contraindications, side-effects, dosage and relative
costs. This allows treatment to be tailored to the individual needs
of each patient. The BNF is updated in print every six months by
an expert team of pharmacists, with guidance and validation from
a network of leading clinicians, overseen by a Joint Formulary
Committee with representatives from all spheres of clinical
practice. The BNF reflects current best practice as well as legal
and professional guidelines relating to the use of medicines. As a
result it is used widely as a touchstone reference, and cited in
Parliaments and courts as a source of authority.